Nestle Health Science US Holdings Inc. 13D and 13G filings for AIMMUNE THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-04-24 4:30 pm Unchanged |
2020-04-22 | 13D | AIMMUNE THERAPEUTICS INC AIMT |
Nestle Health Science US Holdings Inc. | 12,727,113 19.600% |
0 (Unchanged) |
Filing |